Last quarter (Q ), CTI BioPharma's total revenue was $24.12M, an increase of 950.81% from the same quarter last year. In Q, CTI BioPharma's net income was $53.27M. See CTI BioPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 75.77M	$ 53.95M	$ 0.00	$ 0.00	$ 3.35M	$ 26.29M
Cost of Revenue	$ -322.00K	$ -3.51M	-	-	-	$ 879.00K
Gross Profit	$ 73.76M	$ 50.43M	-	-	-	$ 25.41M
Operating Expense	$ 60.99M	$ 130.23M	$ 95.33M	$ 47.77M	$ 43.26M	$ 58.53M
Operating Income	$ 12.77M	$ -79.80M	$ -95.33M	$ -47.77M	$ -39.92M	$ -32.24M
Net Non Operating Interest Income Expense	$ -15.26M	$ -13.14M	$ -2.42M	$ -828.00K	$ -351.00K	$ -515.00K
Other Income Expense	$ 207.00K	$ 56.00K	$ -161.00K	$ -3.85M	$ 245.00K	$ 3.40M
Pretax Income	$ -2.54M	$ -92.99M	$ -97.91M	$ -52.45M	$ -40.02M	$ -29.35M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.54M	$ -92.99M	$ -97.91M	$ -52.45M	$ -40.02M	$ -29.40M
Basic EPS	$ -0.54	$ -0.81	$ -1.09	$ -0.74	$ -0.69	$ -0.52
Diluted EPS	$ -0.54	$ -0.81	$ -1.09	$ -0.74	$ -0.69	$ -0.52
Basic Average Shares	$ 476.39M	$ 114.69M	$ 90.12M	$ 71.14M	$ 57.97M	$ 56.07M
Diluted Average Shares	$ 476.39M	$ 114.69M	$ 90.12M	$ 71.14M	$ 57.97M	$ 56.07M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 60.67M	$ 126.72M	$ 95.33M	$ 47.77M	$ 43.26M	$ 58.53M
Net Income From Continuing And Discontinued Operation	$ -69.24M	$ -92.99M	$ -97.91M	$ -52.45M	$ -40.02M	$ -29.32M
Normalized Income	$ -38.43M	-	$ -97.91M	$ -52.45M	$ -40.27M	$ -28.43M
Interest Expense	$ 7.97M	-	$ 2.45M	$ 511.00K	$ 1.52M	$ 1.73M
EBIT	$ 13.36M	$ -79.85M	$ -95.45M	$ -51.94M	$ -38.50M	$ -27.62M
EBITDA	$ 15.52M	$ -77.90M	$ -94.93M	$ -51.41M	$ -37.95M	$ -27.02M

Currency in USD

CTI BioPharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing